Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Theta rhythms may support executive functions in Parkinson's disease with freezing of gait

Zampogna A, D'Onofrio V, Suppa A.

Clin Neurophysiol. 2022 May;137:181-182. doi: 10.1016/j.clinph.2022.02.007. Epub 2022 Feb 18.

Management of Psychotic Symptoms in a Patient With Parkinson's Disease Maintained on Levodopa-Carbidopa Intestinal Gel by Paliperidone Long-Acting Injection: A Case Report

Alanazi AO, Boqaeid AA, Alnuwaysir MA.

Cureus. 2022 Jan 22;14(1):e21491. doi: 10.7759/cureus.21491. eCollection 2022 Jan.

Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease-Results of a multicenter open trial

Kashihara K, Maeda T, Yoshida K.

Neuropsychopharmacol Rep. 2022 Jun;42(2):135-141. doi: 10.1002/npr2.12235. Epub 2022 Feb 28.

Botulinum toxin for the treatment of tremor

Mittal SO, Pandey S.

J Neurol Sci. 2022 Apr 15;435:120203. doi: 10.1016/j.jns.2022.120203. Epub 2022 Feb 19.

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups.

Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8.

Inflammatory markers and BDNF in obstructive sleep apnea (OSA) in Parkinson's disease (PD)

Kaminska M, O'Sullivan M, Mery VP, Lafontaine AL, Robinson A, Gros P, Martin JG, Benedetti A, Kimoff RJ.

Sleep Med. 2022 Feb;90:258-261. doi: 10.1016/j.sleep.2021.11.018. Epub 2022 Feb 12.

Genotype-phenotype correlation in IARS2-related diseases: A case report and review of literature

Upadia J, Li Y, Walano N, Deputy S, Gajewski K, Andersson HC.

Clin Case Rep. 2022 Feb 24;10(2):e05401. doi: 10.1002/ccr3.5401. eCollection 2022 Feb.

Electroacupuncture ameliorates neuroinflammation in animal models

Xin YY, Wang JX, Xu AJ.

Acupunct Med. 2022 Oct;40(5):474-483. doi: 10.1177/09645284221076515. Epub 2022 Mar 1.

Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective

Banerjee R, Rai A, Iyer SM, Narwal S, Tare M.

Animal Model Exp Med. 2022 Feb;5(1):27-37. doi: 10.1002/ame2.12209. Epub 2022 Jan 27.

Benefits of Virtual Reality Balance Training for Patients With Parkinson Disease: Systematic Review, Meta-analysis, and Meta-Regression of a Randomized Controlled Trial

Wu J, Zhang H, Chen Z, Fu R, Yang H, Zeng H, Ren Z.

JMIR Serious Games. 2022 Mar 1;10(1):e30882. doi: 10.2196/30882.

Effect of cognitive reserve on cognitive function in Parkinson's disease

Gu L, Xu H.

Neurol Sci. 2022 Jul;43(7):4185-4192. doi: 10.1007/s10072-022-05985-1. Epub 2022 Mar 1.

Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders

Catarzi D, Varano F, Vigiani E, Lambertucci C, Spinaci A, Volpini R, Colotta V.

Curr Med Chem. 2022;29(27):4698-4737. doi: 10.2174/0929867329666220301115124.

A Review on Structurally Diversified Synthesized Molecules as Monoacylglycerol Lipase Inhibitors and their Therapeutic uses

Kashyap A, Kumar S, Dutt R.

Curr Drug Res Rev. 2022;14(2):96-115. doi: 10.2174/2589977514666220301111457.

Importance of Indazole against Neurological Disorders

Pal D, Sahu P.

Curr Top Med Chem. 2022;22(14):1136-1151. doi: 10.2174/1568026622666220225152443.

Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils

Jana AK, Lander CW, Chesney AD, Hansmann UHE.

bioRxiv [Preprint]. 2022 Feb 23:2022.02.21.481360. doi: 10.1101/2022.02.21.481360.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias